[RGLS] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
18-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -203.62%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 72 1,194 20,759 7,669 19,569 12,700 13,789 -58.31%
PBT -72,102 -81,840 -55,766 -56,679 -18,691 -17,418 -7,396 46.10%
Tax -197 -4 -18 1 -23 -10 206 -
NP -71,905 -81,836 -55,748 -56,680 -18,668 -17,408 -7,602 45.37%
Tax Rate - - - - - - - -
Total Cost 71,977 83,030 76,507 64,349 38,237 30,108 21,391 22.39%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -99,868.06 -6,853.94 -268.55 -739.08 -95.40 -137.07 -55.13 248.74%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -114.70 -185.94 -130.12 -154.27 -58.22 -254.37 -3,554.00 -43.54%
EPS Diluted -114.70 -185.94 -130.12 -154.27 -58.22 -254.37 -3,554.00 -43.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.